Brewers Ain’t Sweating Over Weight Loss Meds

Dear Client: In last week’s flurry of financial presentations, a common question seemed to work its way into nearly every Q&A… That is, whether these beer leaders have seen or expect any impact from trendy and increasingly popular GLP-1 weight-loss drugs? Recall, these drugs (like Ozempic, Wegovy, Mounjaro, etc) have been touted as a potential headwind to alcohol consumption. You may remember, earlier this fall, that we cited a recent Jefferies survey of ~800 U.S. consumers that revealed that a